West Pharmaceutical Services Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 5 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 346.05.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Media Coverage
The current financial score of West Pharmaceutical Services Inc is 9.68, ranking 1 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 844.90M, representing a year-over-year increase of 21.05%, while its net profit experienced a year-over-year increase of 54.57%.
Key Metrics
The current valuation score of West Pharmaceutical Services Inc is 4.45, ranking 190 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 43.35, which is 36.44% below the recent high of 59.15 and 31.95% above the recent low of 29.50.
The current earnings forecast score of West Pharmaceutical Services Inc is 8.11, ranking 64 out of 206 in the Healthcare Equipment & Supplies industry. The average price target is 350.00, with a high of 390.00 and a low of 285.00.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
The current price momentum score of West Pharmaceutical Services Inc is 9.62, ranking 5 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 351.39 and the support level at 277.51, making it suitable for range-bound swing trading.
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
The current institutional shareholding score of West Pharmaceutical Services Inc is 10.00, ranking 1 out of 206 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 100.32%, representing a quarter-over-quarter increase of 0.29%. The largest institutional shareholder is The Vanguard, holding a total of 9.23M shares, representing 13.06% of shares outstanding, with 2.02% increase in holdings.
The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of West Pharmaceutical Services Inc is 7.55, ranking 36 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.18. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. West Pharmaceutical Services Inc’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.
